Research Article

Nanoencapsulated Quercetin Improves Cardioprotection during Hypoxia-Reoxygenation Injury through Preservation of Mitochondrial Function

Figure 6

Protection of PLGA-quercetin against H-R in H9c2 cells. (a) Viability of H9c2 cells treated 24 h with quercetin or PLGA-quercetin treatments. Lines were fitted to equation (5). (b) H2O2 production rate. (c) Thiols. Note: for (b) and (c), the dose of quercetin, free or encapsulated, was 5 μM. Statistical significance versus NT cells denoted as , for H-R cells denoted as a, and for quercetin-treated cells denoted by b, means .
(a)
(b)
(c)